Creative Planning Corbus Pharmaceuticals Holdings, Inc. Transaction History

Creative Planning

$103 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.11 - $5.46 $0 - $5	1 Added 0.0%	207,025 $22,000
Q4 2021 Feb 11, 2022	SELL	$0.6 - $1.11 $16,211 - $29,991	-27,019 Reduced 11.54%	207,024 $127,000
Q3 2021 Nov 10, 2021	SELL	$1.01 - $1.82 $4,020 - $7,245	-3,981 Reduced 1.67%	234,043 $239,000
Q2 2021 Aug 04, 2021	BUY	$1.39 - $2.21 $5,560 - $8,840	4,000 Added 1.71%	238,024 $436,000
Q4 2020 Jan 29, 2021	SELL	$0.94 - $1.89 $7,520 - $15,120	-8,000 Reduced 3.31%	234,024 $293,000
Q3 2020 Nov 05, 2020	BUY	$1.5 - $9.38 $43,050 - $269,206	28,700 Added 13.45%	242,024 $436,000
Q2 2020 Jul 23, 2020	BUY	$4.79 - $8.39 $991 - $1,736	207 Added 0.1%	213,324 $1.79 Million
Q1 2020 May 05, 2020	BUY	$3.44 - $7.21 $36,484 - $76,469	10,606 Added 5.24%	213,117 $1.12 Million
Q4 2019 Jan 30, 2020	BUY	$4.29 - $5.64 $15,117 - $19,875	3,524 Added 1.77%	202,511 $1.11 Million
Q3 2019 Nov 01, 2019	SELL	$4.87 - $7.08 $540 - $785	-111 Reduced 0.06%	198,987 $969,000
Q2 2019 Jul 26, 2019	SELL	$6.6 - $7.8 $255,657 - $302,140	-38,736 Reduced 16.29%	199,098 $1.38 Million
Q1 2019 Apr 24, 2019	BUY	$5.76 - $8.95 $220,394 - $342,453	38,263 Added 19.17%	237,834 $1.65 Million
Q4 2018 Feb 01, 2019	SELL	$5.26 - $7.97 $12,003 - $18,187	-2,282 Reduced 1.13%	199,571 $1.17 Million
Q3 2018 Oct 25, 2018	BUY	$4.65 - $7.95 $9,448 - $16,154	2,032 Added 1.02%	201,853 $1.52 Million
Q2 2018 Jul 20, 2018	BUY	$5.05 - $6.8 $5,989 - $8,064	1,186 Added 0.6%	199,821 $1.01 Million
Q1 2018 Apr 18, 2018	BUY	$5.6 - $9.25 $109,676 - $181,161	19,585 Added 10.94%	198,635 $1.21 Million
Q4 2017 Jan 17, 2018	BUY	$6.6 - $7.78 $32,194 - $37,950	4,878 Added 2.8%	179,050 $1.27 Million
Q3 2017 Oct 17, 2017	BUY	$5.75 - $7.75 $1 Million - $1.35 Million	174,172	174,172 $1.25 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$229,497
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$18,046
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$15,744
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $853M
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account